Category: Acute Medicine

St Emlyn’s April 2018 blog and podcast round up.

Simon and Iain talk through what the team has been up to in April. All the blogs should be on the website and of course you can subscribe to the podcast via iTunes or via

#badEMfest18 Day 1. St Emlyn’s

Last week the St Emlyn’s team in the form of Janos Baombe, Natalie May, Ross Fisher and myself travelled to Greyton for the very first #badEMfest18. This is a conference with a real difference. Set

Is cMyC the new troponin?

Anyone who reads the news is likely to have seen the recent paper in Circulation evaluating a new biomarker of acute coronary syndromes: cardiac myosin binding protein C (cMyC) . This paper has been covered

Icatibant for ACE inhibitor induced angioedema

Patients presenting to the ED are tending to get older, have more co-morbidities and take more medications. As this happens, in my experience we seem to see more patients with complications of those medications. Something

Getting your chest pain evaluation right: #UMECS16

Last week, while Iain was giving a keynote lecture in Austria, I was also heading for distant shores to speak about chest pain evaluation at a special conference set up by the legendary Amal Mattu:

All you need to know about CHEMSEX but never dared to ask… St.Emlyn’s

CHEMSEX and public health issues for the emergency department and physician.

Taking a sexual history in ED

Emergency physicians often feel that taking a sexual history in EDs is something medical school and specialty training have not prepared them very well for. This comes as no surprise as it differs significantly from

The MACS rule: a new user-friendly version

This blog post is based on a paper we’ve just had published in the Emergency Medicine Journal entitled: ‘The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty

Get the NOAC Knowhow: Novel Oral Anticoagulants Part 1

Where would we be without warfarin?  The good old rat poison has served us brilliantly for decades, allowing us to anticoagulate patients to treat and prevent venous thromboembolism, prevent stroke in AF, and so much

Translate »